Now, huge strides have been made in medicine, as Lynne outlined, and in other cancers like childhood leukaemia, Hodgkin's disease and many other cancers, as outlined, survival rates have been dramatically, radically transformed over the years. All of those conditions did have a particular focus at the time, though, in terms of we said at the time, 'Childhood leukaemia: why are children dying? Let's have a particular focus on that. Let's sort it out.' That was 25 years ago, now. But, it hasn't happened for pancreatic cancer, and that's why we're having this debate today.

The distressing case studies that we've heard from Lynne, from Delyth, from Neil McEvoy and others demand action and a focus on pancreatic cancer. And by demanding focus, we mean that 'focus' means increased funding for this particular cancer, and it does actually mean serious consideration, and I would be campaigning to set up this specialist tertiary surgical centre. I think that is the transformational element that needs to happen. As the Minister said, surgery is curative, so let's enable the very best surgery targeted at this hugely malignant cancer. That single hepatobiliary pancreatic surgical centre needs to happen. That is the transformative action; that is the fast-track surgery; that's the early diagnosis; that's what needs to happen.

Because it is really tough to diagnose this. People present with really vague symptoms that could be anything or nothing, as Delyth said in her distressing case involving mam-gu. It is hugely difficult to pick up the signs, because we can't, as GPs refer everybody who comes along with a bit of tummy pain and not feeling well and feeling a bit off colour, otherwise our hospitals would be full—[Interruption.] They are. And diagnostic tests to improve research have worked for other conditions that we thought never had a diagnostic test. That's why the emphasis is on research here, as well, to find that test. 

So, I'm grateful to David Melding as well for paying tribute to Pancreatic Cancer UK, a tribute to their great work. Much research is going on and it's research that will transform the field. People say, 'You're always talking about research, it's a bit tedious', but that's where all these medical advances have come about. Tremendous research enables medical technology, medical treatments, and medical advances to truly take off. Cancer Research UK, Cancer Research Wales—everybody is doing a phenomenal amount of innovative research. And Delyth reminded us that November is Pancreatic Cancer Awareness Month, and again, emphasising the trauma of the diagnosis, and the need for a national plan, as we're already saying—this national focus uniquely for pancreatic cancer. 

I'm grateful also to Caroline Jones for her personal experience and her support for this motion, and also for Neil McEvoy's words on the fast-track surgery, and his personal experience. I'm grateful to the Minister as well, before closing, in terms of, obviously acknowledging the excellent work that is done by our excellent staff in the NHS at the moment. Improvements are happening, but, uniquely for pancreatic cancer, we still haven't seen that step change in survival rates. So, we have to have that focus on funding, on that setting up of a single hepatobiliary pancreatic surgical centre; I look forward to the day—the Minister could even open it. We need a focus. I hear the words about the single cancer pathway—absolutely fantastic—but within that, there needs to be a particular emphasis on what we can do about this silent, and not-so-silent killer, that is pancreatic cancer.

So, cancer of the pancreas—in closing, Deputy Presiding Officer—demands a particular focus. It's had a particular focus here in the Chamber this afternoon. I am grateful for the contribution of all Members. Yes, we can learn from other countries, other centres, we can learn from the rapid diagnosis pilots. We need to take all that on board but also work and step up to the challenge and support the motion. Diolch yn fawr.